drug · cell
remestemcel-L
Phase 3updated 3mo agoby $MESO MESOBLAST LTD🔗 ChEMBL
Phase 3community read0 votes
Cell drug with a maximum clinical stage of Phase 3 (across all indications), with 9 investigational indications.
indications
indications
Duchenne Muscular Dystrophy
all catalysts(0)
nothing on the calendar yet
Trials studying remestemcel-L
- phase2Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis
- phase2Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)
- phase2PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
- phase2PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
- phase3Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease
- phase2Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)
- phase3Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
- phase3Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that